SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-025787
Filing Date
2022-11-03
Accepted
2022-11-03 16:45:47
Documents
86
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbyi20220930_10q.htm   iXBRL 10-Q 1501228
2 EXHIBIT 10.1 ex_440535.htm EX-10.1 43899
3 EXHIBIT 10.2 ex_440480.htm EX-10.2 271673
4 EXHIBIT 31.1 ex_417270.htm EX-31.1 8215
5 EXHIBIT 31.2 ex_417271.htm EX-31.2 8214
6 EXHIBIT 32.1 ex_417272.htm EX-32.1 5100
7 EXHIBIT 32.2 ex_417273.htm EX-32.2 5118
  Complete submission text file 0001437749-22-025787.txt   8202468

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA pbyi-20220930.xsd EX-101.SCH 75180
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbyi-20220930_cal.xml EX-101.CAL 67711
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbyi-20220930_def.xml EX-101.DEF 481141
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbyi-20220930_lab.xml EX-101.LAB 443787
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbyi-20220930_pre.xml EX-101.PRE 518694
80 EXTRACTED XBRL INSTANCE DOCUMENT pbyi20220930_10q_htm.xml XML 1273971
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35703 | Film No.: 221358739
SIC: 2834 Pharmaceutical Preparations